Otsuka Pakistan Limited (OPL) is engaged in the manufacturing, marketing and distribution of intravenous (IV) infusions and trading in pharmaceutical products, nutritional foods and medical equipment. The Company's activities are focused on the manufacturing of IV Solutions and marketing them. The Company provides international solutions and medicines to doctors, hospitals and pharmacies. The Company's products include intravenous solutions, cardiac stents, clinical nutrition and therapeutic drugs. Its intravenous solutions include electrolyte solutions, standard solutions, ampoules and others. The Company offers various cardiac stents, such as firebird, jive, mustang and tango. The clinical nutrition products include aminoleban oral, aminovel 600, pan-amin g, pan-amin sg and aminoleban injection. Pletaal is the therapeutic drug of the Company. The Company's subsidiary is Messrs Otsuka Pharmaceutical Company Limited.